Concepedia

Gillian L. Hirst

GL

Statistics

Publications

55

Citations

5.2K

H-Index

29

Active since

1993

Affiliations

University of California, San Francisco(Current)

The University of Texas MD Anderson Cancer Center

University of Pennsylvania

Quantum Leap Healthcare Collaborative

University of Minnesota

Gillian L. Hirst is an author at University of California, San Francisco specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1993–2025

55

Publications

55

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

Rita Nanda, Minetta C. Liu, Christina Yau et al. · JAMA Oncology · 2020 · 706 citations · Full text

, , +16

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele et al. · New England Journal of Medicine · 2016 · 555 citations · Full text

, , +13

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee et al. · New England Journal of Medicine · 2016 · 460 citations · Full text

, , +17

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

Mark Jesus M. Magbanua, Lamorna Brown Swigart, H.-T. Wu et al. · Annals of Oncology · 2020 · 438 citations · Full text

, , +17

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Lajos Pusztai, Christina Yau, Denise M. Wolf et al. · Cancer Cell · 2021 · 330 citations · Full text

, , +10

1–5 of 55